Gen/Surg Panel Okays Dermal Fillers 6-3; Minority Patient Studies Proposed
This article was originally published in The Gray Sheet
Executive Summary
Medicis/Q-Med plan to conduct a 100-patient, Phase IV study to evaluate Restylane non-animal stabilized hyaluronic acid-based wrinkle gel in "people of color," in accordance with FDA panel recommendations